Headquartered in Hamilton, Ontario, Canada, Delivra Corp. (“Delivra”) is a developer of transdermal technologies for the delivery of pharmaceutical and natural molecules, through the skin, rather than via pills.

Delivra manufactures and sells a growing line of natural topical creams under the LivReliefTM brand, for conditions such as joint and muscle pain, nerve pain, varicose veins, wound healing, and under the LivSportTM brand for sports performance. LivReliefTM products are available in pharmacies, grocery chains, and independent health food stores across Canada, and on-line at www.livrelief.com.

In parallel with its consumer products business, Delivra also has a mandate to license its patent-pending delivery platform to pharmaceutical companies globally for the transdermal delivery of third party active ingredients to treat a broad range of conditions.

Delivra is a publicly traded company, listed on the TSX Venture Exchange under the symbol DVA.

DVA Investor Presentation (PDF) DVA Annual General Meeting Presentation (PDF) Analyst Report (PDF) As CBD Oil Flirts with Mainstream, Questions Mount (Link) The new topicals – So much more than pain relief & pediatrics in the age of polypharmacy (Link)

For investor relations information, please contact mailto:info@delivracorp.com